Lazard International Strategic Equity has the ingredients to succeed but needs to deliver on its advantages.
Lazard International Strategic Eq Open LISOX
- NAV / 1-Day Return 16.91 / −1.00 %
- Total Assets 3.7 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.080%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Foreign Large Blend
- Investment Style Large Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 1.16%
- Turnover 43%
USD | NAV as of Sep 27, 2024 | 1-Day Return as of Sep 27, 2024, 10:16 PM GMT+0
Morningstar’s Analysis LISOX
Will LISOX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 29.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 5.48 | 203.3 Mil | Healthcare |
ASML Holding NV | 4.34 | 161.0 Mil | Technology |
RELX PLC | 3.31 | 122.8 Mil | Industrials |
Icon PLC | 2.82 | 104.7 Mil | Healthcare |
Siemens AG | 2.45 | 90.8 Mil | Industrials |
Aon PLC Class A | 2.37 | 87.8 Mil | Financial Services |
Coca-Cola Europacific Partners PLC | 2.33 | 86.4 Mil | Consumer Defensive |
ABB Ltd | 2.21 | 82.1 Mil | Industrials |
Accenture PLC Class A | 2.17 | 80.6 Mil | Technology |
Airbus SE | 2.12 | 78.5 Mil | Industrials |